- Investing.com
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, pain management, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. Abbott India Limited was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.
Metrics to compare | ABOT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABOTPeersSector | |
---|---|---|---|---|
P/E Ratio | 49.3x | 33.1x | −0.5x | |
PEG Ratio | 2.78 | 1.07 | 0.00 | |
Price/Book | 16.5x | 5.3x | 2.6x | |
Price / LTM Sales | 10.9x | 6.1x | 3.3x | |
Upside (Analyst Target) | 5.9% | 13.4% | 43.3% | |
Fair Value Upside | Unlock | −0.4% | 6.9% | Unlock |